AU532783B2 - 4-aroyl-imazol-2-ones - Google Patents

4-aroyl-imazol-2-ones

Info

Publication number
AU532783B2
AU532783B2 AU59118/80A AU5911880A AU532783B2 AU 532783 B2 AU532783 B2 AU 532783B2 AU 59118/80 A AU59118/80 A AU 59118/80A AU 5911880 A AU5911880 A AU 5911880A AU 532783 B2 AU532783 B2 AU 532783B2
Authority
AU
Australia
Prior art keywords
imazol
aroyl
ones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU59118/80A
Other languages
English (en)
Other versions
AU5911880A (en
Inventor
Richard C. Dage
J. Martin Grisar
Richard A. Schettler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26727558&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU532783(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of AU5911880A publication Critical patent/AU5911880A/en
Application granted granted Critical
Publication of AU532783B2 publication Critical patent/AU532783B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU59118/80A 1979-06-18 1980-06-06 4-aroyl-imazol-2-ones Expired AU532783B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US4980879A 1979-06-18 1979-06-18
US49808 1979-06-18
US11920780A 1980-02-07 1980-02-07
US119207 1980-02-07

Publications (2)

Publication Number Publication Date
AU5911880A AU5911880A (en) 1981-01-08
AU532783B2 true AU532783B2 (en) 1983-10-13

Family

ID=26727558

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59118/80A Expired AU532783B2 (en) 1979-06-18 1980-06-06 4-aroyl-imazol-2-ones

Country Status (20)

Country Link
AT (1) AT375349B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU532783B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1132554A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH646155A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3021792A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK160269C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES8105299A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2459233A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2055364B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK61486A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU186736B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE50646B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL60243A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1143922B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY8600709A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (2) NL193752C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO152841C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ193935A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH18683A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (2) SE447107B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones
US4405628A (en) * 1981-03-05 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Pyridylimidazolones and method of use
US4329471A (en) * 1981-05-04 1982-05-11 Merrell Dow Pharmaceuticals Inc. 4-(4-Phenyl-1-piperidinyl)methyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones
US4526981A (en) * 1981-05-04 1985-07-02 Merrell Dow Pharmaceuticals Inc. [1,2-Dihydro-4(5)-acyl-2-oxo-2H-imidazol-4(5)-yl] methyl nitrates
US4371737A (en) * 1981-05-04 1983-02-01 Merrell Dow Pharmaceuticals Inc. 5-Aminomethyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives
US4381393A (en) * 1981-05-04 1983-04-26 Merrell Dow Pharmaceuticals Inc. 4-Aminomethyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones
CA1167853A (en) * 1981-05-04 1984-05-22 J. Martin Grisar 4-oxymethyl-5-acyl-1,3-dihydro-2h-imidazol-2-ones
US4329470A (en) * 1981-05-04 1982-05-11 Merrell Dow Pharmaceuticals Inc. 5-(4-Phenyl 1-piperidinyl)methyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives
US4367236A (en) * 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US4410540A (en) * 1981-11-04 1983-10-18 Merrell Dow Pharmaceuticals Inc. Cardiotonic 4-aroylimidazolidin-2-ones
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US20060030611A1 (en) * 2004-03-22 2006-02-09 Myogen, Inc. Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases
JP2007530563A (ja) * 2004-03-22 2007-11-01 ミオゲン インコーポレイティッド （ｓ）−エノキシモンスルホキシドおよびｐｄｅ−ｉｉｉ媒介疾患の治療におけるその使用
EP1956906A4 (en) 2005-11-09 2009-12-30 Combinatorx Inc METHODS, COMPOSITIONS AND KITS FOR THE TREATMENT OF PATHOLOGIES
EP2998314B1 (en) 2007-06-04 2020-01-22 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP3366698A1 (en) 2011-03-01 2018-08-29 Synergy Pharmaceuticals Inc. Guanylate cyclase c agonists
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use
CA2902348C (en) 2013-02-25 2021-11-30 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
RS65632B1 (sr) 2013-06-05 2024-07-31 Bausch Health Ireland Ltd Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe
KR20220147691A (ko) 2013-08-09 2022-11-03 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient
CN114539157B (zh) * 2022-03-03 2023-12-22 曲靖师范学院 一种碘促进氧化法制备4-碘代n-芳基吡唑类化合物的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them

Also Published As

Publication number Publication date
NL193752C (nl) 2000-09-04
ATA314280A (de) 1983-12-15
DK160269C (da) 1991-07-22
NO152841B (no) 1985-08-19
SE8501452L (sv) 1985-03-25
FR2459233A1 (fr) 1981-01-09
DE3021792A1 (de) 1981-01-22
GB2055364A (en) 1981-03-04
SE464559B (sv) 1991-05-13
GB2055364B (en) 1983-06-08
NO801796L (no) 1980-12-19
HU186736B (en) 1985-09-30
IL60243A0 (en) 1980-09-16
IL60243A (en) 1987-01-30
AT375349B (de) 1984-07-25
DK160269B (da) 1991-02-18
NZ193935A (en) 1985-05-31
AU5911880A (en) 1981-01-08
FR2459233B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1983-09-23
NL193752B (nl) 2000-05-01
MY8600709A (en) 1986-12-31
ES492255A0 (es) 1981-06-01
NL300015I1 (nl) 2000-11-01
PH18683A (en) 1985-08-29
NL300015I2 (nl) 2000-10-02
SE8501452D0 (sv) 1985-03-25
SE447107B (sv) 1986-10-27
HK61486A (en) 1986-08-29
CA1132554A (en) 1982-09-28
DK259080A (da) 1980-12-19
IE801162L (en) 1980-12-18
CH646155A5 (de) 1984-11-15
IT1143922B (it) 1986-10-29
SE8004253L (sv) 1980-12-19
NL8003498A (nl) 1980-12-22
NO152841C (no) 1985-11-27
ES8105299A1 (es) 1981-06-01
IT8048997A0 (it) 1980-06-17
DE3021792C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-08-10
IE50646B1 (en) 1986-06-11

Similar Documents

Publication Publication Date Title
AU532879B2 (en) 1-aryl-2-acylamido-3-fluoro-1-propanols
AU548070B2 (en) Arylsulphonyls
AU532626B2 (en) Monacolink
AU541091B2 (en) Azolyloxy-carboxylic acid -oxy-amides
AU532090B2 (en) Emmitter
AU532783B2 (en) 4-aroyl-imazol-2-ones
AU535632B2 (en) Cyclo-octapeptides
AU537592B2 (en) Mercaptoacyldipeptides
AU533526B2 (en) Polyether-polyamines
AU529508B2 (en) 6-n-propyl-8alpha-methoxymethyl or -methylmercaptomethyl -ergolines
AU525431B2 (en) Emulsans
AU532884B2 (en) Vinyl-cephalosporins
AU527992B2 (en) 9-aminoalkylfluorenes
AU528665B2 (en) Breathalyser
AU532763B2 (en) 8-aminoalkyl-4-alkylpsoralens
AU539187B2 (en) Pyrazinobenzodiazepines
AU533807B2 (en) Pyridothienotriazines
AU538025B2 (en) N-cyanoimidate
AU531808B2 (en) Tetrahydrobenzothiazolylimidazolidinones
AU531811B2 (en) Thiazolylidene-oxo-propionitriles
AU532359B2 (en) 2-amino-3-benzoyl-phenylacetamides
AU532700B2 (en) Diphenylalkanoether
AU536556B2 (en) Aldehyde-ethers
AU538686B2 (en) 1-substituted-2-pyrrolidinones
AU528075B2 (en) Z-aza-ergolines

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired